View in EDS

Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia.

Saved in:
Bibliographic Details
Transliterated Title: Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia.
Authors: Marcellusi A; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italia.; Institute for Leadership and Management in Health - Kingston University London, London - UK., Bini C; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italia., Rotundo MA; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italia., Cultrera R; Dipartimento di Morfologia, Chirurgia e Medicina sperimentale, Università degli Studi di Ferrara, Ferrara - Italia., Mennini FS; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italia.; Institute for Leadership and Management in Health - Kingston University London, London - UK.
Source: Global & regional health technology assessment [Glob Reg Health Technol Assess] 2020 Nov 06; Vol. 7, pp. 92-100. Date of Electronic Publication: 2020 Nov 06 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: AboutScience Country of Publication: Italy NLM ID: 9918417986506676 Publication Model: eCollection Cited Medium: Internet ISSN: 2283-5733 (Electronic) Linking ISSN: 22842403 NLM ISO Abbreviation: Glob Reg Health Technol Assess Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36627961
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data:
– Name: TitleTranslated
  Label: Transliterated Title
  Group: TiAlt
  Data: Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Marcellusi+A%22">Marcellusi A</searchLink>; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italia.; Institute for Leadership and Management in Health - Kingston University London, London - UK.<br /><searchLink fieldCode="AU" term="%22Bini+C%22">Bini C</searchLink>; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italia.<br /><searchLink fieldCode="AU" term="%22Rotundo+MA%22">Rotundo MA</searchLink>; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italia.<br /><searchLink fieldCode="AU" term="%22Cultrera+R%22">Cultrera R</searchLink>; Dipartimento di Morfologia, Chirurgia e Medicina sperimentale, Università degli Studi di Ferrara, Ferrara - Italia.<br /><searchLink fieldCode="AU" term="%22Mennini+FS%22">Mennini FS</searchLink>; Faculty of Economics, Economic Evaluation and HTA (EEHTA), CEIS, University of Rome 'Tor Vergata', Rome - Italia.; Institute for Leadership and Management in Health - Kingston University London, London - UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918417986506676%22">Global & regional health technology assessment</searchLink> [Glob Reg Health Technol Assess] 2020 Nov 06; Vol. 7, pp. 92-100. <i>Date of Electronic Publication: </i>2020 Nov 06 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AboutScience%22">AboutScience </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>9918417986506676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2283-5733 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2222842403%22">22842403 </searchLink><i>NLM ISO Abbreviation: </i>Glob Reg Health Technol Assess <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36627961
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.33393/grhta.2020.2138
    Languages:
      – Code: ita
        Text: Italian
    PhysicalDescription:
      Pagination:
        StartPage: 92
    Titles:
      – TitleFull: Costo-utilità di dalbavancina versus standard of care (SoC) in pazienti con ABSSSI non severa in Italia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Marcellusi A
      – PersonEntity:
          Name:
            NameFull: Bini C
      – PersonEntity:
          Name:
            NameFull: Rotundo MA
      – PersonEntity:
          Name:
            NameFull: Cultrera R
      – PersonEntity:
          Name:
            NameFull: Mennini FS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 11
              Text: 2020 Nov 06
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2283-5733
          Numbering:
            – Type: volume
              Value: 7
          Titles:
            – TitleFull: Global & regional health technology assessment
              Type: main
ResultId 1